Cardiff Oncology
CRDF
CRDF
67 hedge funds and large institutions have $264M invested in Cardiff Oncology in 2020 Q3 according to their latest regulatory filings, with 43 funds opening new positions, 12 increasing their positions, 6 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more funds holding
Funds holding: →
100% more repeat investments, than reductions
Existing positions increased: 12 | Existing positions reduced: 6
50.19% more ownership
Funds ownership: 24.66% → 74.84% (+50%)
4% less call options, than puts
Call options by funds: $8.46M | Put options by funds: $8.85M
Holders
67
Holding in Top 10
5
Calls
$8.46M
Puts
$8.85M
Top Buyers
| 1 | +$46.7M | |
| 2 | +$18M | |
| 3 | +$16.2M | |
| 4 |
Janus Henderson Group
London,
United Kingdom
|
+$14.4M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
+$13.9M |
Top Sellers
| 1 | -$5.01M | |
| 2 | -$1.44M | |
| 3 | -$1.35M | |
| 4 |
PFS
Prospera Financial Services
Dallas,
Texas
|
-$483K |
| 5 |
Morgan Stanley
New York
|
-$181K |